Dissimuler ce message

Bienvenue au Centre de Ressources sur les Entreprises et les Droits de l’Homme.

Nous nous faisons un devoir de travailler avec les militants de la société civile, les entreprises et les gouvernements afin d’aborder les inégalités de pouvoir, d’identifier les voies recours en cas d’abus, et d’assurer la protection des individus et de la planète.

Les entreprises et les communautés affectées nous remercient toutes deux des ressources et du soutien que nous leur apportons.

Ceci est uniquement possible grâce à votre soutien. S’il vous plaît, songez à faire un don dès aujourd’hui.

Merci,
Phil Bloomer, Directeur Exécutif

Faire un don maintenant Dissimuler ce message

Association américaine des industries du médicament (PhRMA)

Souscrire au flux RSS de cette rubrique

Histoire et composants dans cette catégorie

Document
15 October 2014
+ English - Cacher

Auteur: CBS 60 Minutes (USA)

"The Cost of Cancer Drugs", 5 Oct 2014...

Lire la suite

Article
10 September 2013
+ English - Cacher

Auteur: Sebastian Krueger, Open Society Foundations

Patent protections allow for inflated monopoly pricing and keep generic drugs, which are cheaper, from going to market. Secret international trade deals impose the pharmaceutical companies’ high prices on foreign nations...But Fire in the Blood asks us...

Lire la suite

Article
21 September 2011
+ English - Cacher

Auteur: David Brown, Washington Post

Behind...talks at the United Nations and a...document about the need to fight noncommunicable diseases...is a fierce struggle between commercial and health interests...Some of the issues...are the same ones at the heart of...the battle against smoking...

Lire la suite

Histoire
23 February 2009
+ English - Cacher
Article
23 February 2009
+ English - Cacher

Auteur: Global Health Progress Initiative

Promoting health among the world's poorest populations brought leaders from various nations, the global health community, biopharmaceutical companies, the media and international non-governmental organizations (NGOs) together today... The United...

Lire la suite

Article
23 February 2009
+ English - Cacher

Auteur: United Nations Economic and Social Council (ECOSOC)

Lire la suite

Article
23 June 2007
+ English - Cacher

Auteur: Bloomberg

Thailand plans to buy more generic AIDS drugs from India to cut the cost of treating its poorest patients after failing to win large enough discounts from drug makers including Merck & Co. and Abbott Laboratories…Public health minister, Mongkol Na...

Lire la suite

Article
14 February 2007
+ English - Cacher

Auteur: Keya Acharya, Inter Press Service

Under the drug regulatory process any drug, whether patented or not, must pass safety, efficacy and quality tests for marketing from the Drug Controller-General of India (DGCI)...the DGCI can [currently] rely on previous test data to approve subsequent...

Lire la suite

Article
3 January 2007
+ English - Cacher

Auteur: John Carreyrou, The Wall Street Journal [USA]

In the fall of 2003, Abbott Laboratories...seized on an unusual weapon that helped [its AIDS drug] Kaletra's global sales top $1 billion a year, even as it exposed Abbott to criticism that it was endangering patients. The weapon was an older Abbott...

Lire la suite

Article
31 May 2005
+ English - Cacher

Auteur: Alex Berenson, New York Times

When the drug industry came under fire last summer for failing to disclose poor results from studies of antidepressants, major drug makers promised to provide more information about their research on new medicines...Eli Lilly and some other companies...

Lire la suite